Palatin Technologies Inc
PTN0.094USD
-0.076-44.65%
交易中 （美東）報價延遲15分鐘
2.21M總市值
虧損本益比TTM
關於 Palatin Technologies Inc 公司
Palatin Technologies, Inc. 是一家生物製藥公司。該公司致力於開發基於調節黑皮質素受體系統活性的分子的藥物。該公司的候選產品是針對性受體特異性治療藥物，用於治療具有未滿足醫療需求和商業潛力的疾病。其新產品開發活動主要集中在 MC1r 激動劑上，具有治療炎症和自身免疫性疾病的潛力，例如干眼症（也稱爲乾燥性角結膜炎）、葡萄膜炎、糖尿病視網膜病變和炎症性腸病。該公司還在開發對多種黑皮質素受體有活性的肽，以及 MC4r 肽和小分子激動劑，這些激動劑可能用於治療肥胖和代謝相關疾病，包括罕見疾病和孤兒適應症。其候選產品包括用於治療乾眼症的 PL9643 和用於治療潰瘍性結腸炎的 PL8177。
公司簡介
公司代碼PTN
公司名稱Palatin Technologies Inc
上市日期Dec 21, 1999
成立日期1986
CEODr. Carl Spana, Ph.D.
員工數量30
證券類型Ordinary Share
年結日Dec 21
公司地址4B Cedar Brook Drive
城市CRANBURY
上市交易所NYSE American Consolidated
國家United States of America
郵編08512
電話16094952200
網址https://www.palatin.com/
公司代碼PTN
上市日期Dec 21, 1999
成立日期1986
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Carl Spana, Ph.D.
Dr. Carl Spana, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
261.46K
-23.20%
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
235.46K
-22.66%
Mr. Joseph Stanley Hull
Mr. Joseph Stanley Hull
Independent Director
Independent Director
30.27K
-28.39%
Dr. Anthony M. Manning, Ph.D.
Dr. Anthony M. Manning, Ph.D.
Independent Director
Independent Director
24.08K
-33.26%
Ms. Arlene M. Morris
Ms. Arlene M. Morris
Independent Director
Independent Director
--
--
Dr. John K. A. Prendergast
Dr. John K. A. Prendergast
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Robert K. Deveer, Jr.
Mr. Robert K. Deveer, Jr.
Independent Director
Independent Director
--
--
Dr. Alan William Dunton, M.D.
Dr. Alan William Dunton, M.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Carl Spana, Ph.D.
Dr. Carl Spana, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
261.46K
-23.20%
Mr. Stephen T. Wills, CPA
Mr. Stephen T. Wills, CPA
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer, Secretary
235.46K
-22.66%
Mr. Joseph Stanley Hull
Mr. Joseph Stanley Hull
Independent Director
Independent Director
30.27K
-28.39%
Dr. Anthony M. Manning, Ph.D.
Dr. Anthony M. Manning, Ph.D.
Independent Director
Independent Director
24.08K
-33.26%
Ms. Arlene M. Morris
Ms. Arlene M. Morris
Independent Director
Independent Director
--
--
Dr. John K. A. Prendergast
Dr. John K. A. Prendergast
Independent Chairman of the Board
Independent Chairman of the Board
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Armistice Capital LLC
3.60%
Integral Health Asset Management, LLC
2.15%
The Vanguard Group, Inc.
1.27%
Spana (Carl)
0.56%
Geode Capital Management, L.L.C.
0.55%
Other
91.86%
持股股東
持股股東
佔比
Armistice Capital LLC
3.60%
Integral Health Asset Management, LLC
2.15%
The Vanguard Group, Inc.
1.27%
Spana (Carl)
0.56%
Geode Capital Management, L.L.C.
0.55%
Other
91.86%
股東類型
持股股東
佔比
Hedge Fund
5.82%
Investment Advisor/Hedge Fund
2.69%
Individual Investor
1.69%
Investment Advisor
0.90%
Research Firm
0.02%
Other
88.88%
機構持股
更新時間: 3月4日 週二
更新時間: 3月4日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
84
4.38M
16.86%
+1.71M
2024Q4
86
4.37M
16.81%
+1.70M
2024Q3
83
2.28M
10.81%
-1.78M
2024Q2
109
3.64M
20.41%
+1.60M
2024Q1
111
1.78M
11.91%
-743.00K
2023Q4
114
2.29M
17.05%
-582.75K
2023Q3
116
2.63M
22.43%
+838.36K
2023Q2
118
2.93M
25.24%
+1.19M
2023Q1
127
1.23M
11.29%
-1.28M
2022Q4
138
2.01M
19.55%
+390.54K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Armistice Capital LLC
1.99M
7.66%
+1.99M
--
Dec 31, 2024
The Vanguard Group, Inc.
591.85K
2.28%
-1.97K
-0.33%
Dec 31, 2024
Spana (Carl)
261.46K
1.01%
-79.00K
-23.20%
Sep 27, 2024
Geode Capital Management, L.L.C.
190.55K
0.73%
+8.85K
+4.87%
Dec 31, 2024
Wills (Stephen T)
235.46K
0.91%
-69.00K
-22.66%
Sep 27, 2024
Squarepoint Capital LLP
30.79K
0.12%
+30.79K
--
Dec 31, 2024
LPL Financial LLC
186.31K
0.72%
-84.00
-0.05%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
156.04K
0.6%
+248.00
+0.16%
Dec 31, 2024
deVeer (Robert K Jr)
26.07K
0.1%
-12.00K
-31.53%
Sep 27, 2024
查看更多
持股ETF
更新時間: 6月6日 週五
更新時間: 6月6日 週五
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Micro-Cap ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
Dimensional US Core Equity 1 ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
公告日期
類型
比率
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
Aug 22, 2022
Merger
25<1
